Title : Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs.

Pub. Date : 2014 Apr

PMID : 24461644






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs. cimicoxib cytochrome c oxidase subunit II Canis lupus familiaris
2 Cimicoxib (CX) is a novel imidazole derivative that is a cyclo-oxygenase (COX)-2 selective non-steroidal anti-inflammatory drug and the latest COX-2 selective inhibitor to be released for veterinary use. cimicoxib cytochrome c oxidase subunit II Canis lupus familiaris
3 Cimicoxib (CX) is a novel imidazole derivative that is a cyclo-oxygenase (COX)-2 selective non-steroidal anti-inflammatory drug and the latest COX-2 selective inhibitor to be released for veterinary use. cimicoxib cytochrome c oxidase subunit II Canis lupus familiaris
4 Cimicoxib (CX) is a novel imidazole derivative that is a cyclo-oxygenase (COX)-2 selective non-steroidal anti-inflammatory drug and the latest COX-2 selective inhibitor to be released for veterinary use. cimicoxib cytochrome c oxidase subunit II Canis lupus familiaris
5 Cimicoxib (CX) is a novel imidazole derivative that is a cyclo-oxygenase (COX)-2 selective non-steroidal anti-inflammatory drug and the latest COX-2 selective inhibitor to be released for veterinary use. cimicoxib cytochrome c oxidase subunit II Canis lupus familiaris